Literature DB >> 8180202

Glycosylation of human corticosteroid-binding globulin. Differential processing and significance of carbohydrate chains at individual sites.

G V Avvakumov1, G L Hammond.   

Abstract

Human corticosteroid-binding globulin (CBG) comprises 383 amino acids and six consensus sites for attachment of N-acetyllactosamine-type oligosaccharides. To study the extent of addition and processing of individual carbohydrate chains, we expressed CBG mutants, each containing only one of the six possible glycosylation sites, in Chinese hamster ovary cells and examined their electrophoretic, immunochemical, and lectin-binding properties. This indicated that Asn9, Asn308, and Asn347 are partially glycosylated and that oligosaccharides attached to Asn9, Asn238, Asn308, and Asn347 are predominantly biantennary, while more branched (most likely, triantennary) oligosaccharides are preferentially linked to Asn74 and Asn154. Only one of the biantennary chains (attached to Asn9) contains significant amounts of fucose. These data indicate that oligosaccharide processing is site-specific, and analyses of three other mutants, in which an additional glycosylation site was preserved, demonstrated that the processing of individual oligosaccharides occurs independently. Thus, the glycosylation of recombinant CBG appears to resemble that of natural human CBG. As we have previously found, glycosylation at Asn238 is essential for the production of CBG with steroid-binding activity, but when the mutant containing only one oligosaccharide at this position was enzymatically deglycosylated, its steroid-binding activity was unaltered. This suggests that interaction between this carbohydrate chain and the polypeptide is necessary for the folding and creation of the steroid-binding site only during CBG biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8180202     DOI: 10.1021/bi00185a012

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Corticosteroid-binding globulin is a biomarker of inflammation onset and severity in female rats.

Authors:  Lesley A Hill; Tamara S Bodnar; Joanne Weinberg; Geoffrey L Hammond
Journal:  J Endocrinol       Date:  2016-08       Impact factor: 4.286

2.  N-glycans modulate the function of human corticosteroid-binding globulin.

Authors:  Zeynep Sumer-Bayraktar; Daniel Kolarich; Matthew P Campbell; Sinan Ali; Nicolle H Packer; Morten Thaysen-Andersen
Journal:  Mol Cell Proteomics       Date:  2011-05-10       Impact factor: 5.911

3.  Asn347 Glycosylation of Corticosteroid-binding Globulin Fine-tunes the Host Immune Response by Modulating Proteolysis by Pseudomonas aeruginosa and Neutrophil Elastase.

Authors:  Zeynep Sumer-Bayraktar; Oliver C Grant; Vignesh Venkatakrishnan; Robert J Woods; Nicolle H Packer; Morten Thaysen-Andersen
Journal:  J Biol Chem       Date:  2016-06-23       Impact factor: 5.157

4.  Differential Effects of Estrogen on Corticosteroid-Binding Globulin Forms Suggests Reduced Cleavage in Pregnancy.

Authors:  Marni A Nenke; Anna Zeng; Emily J Meyer; John G Lewis; Wayne Rankin; Julie Johnston; Svjetlana Kireta; Shilpanjali Jesudason; David J Torpy
Journal:  J Endocr Soc       Date:  2017-02-13

5.  Functional implications of corticosteroid-binding globulin N-glycosylation.

Authors:  Marc Simard; Caroline Underhill; Geoffrey L Hammond
Journal:  J Mol Endocrinol       Date:  2017-12-22       Impact factor: 5.098

6.  Glycosylation deficiency of lipopolysaccharide-binding protein and corticosteroid-binding globulin associated with activity and response to treatment for rheumatoid arthritis.

Authors:  Federica Ciregia; Dominique Baiwir; Gaël Cobraiville; Thibaut Dewael; Gabriel Mazzucchelli; Valérie Badot; Silvana Di Romana; Paschalis Sidiras; Tatiana Sokolova; Patrick Durez; Michel G Malaise; Dominique de Seny
Journal:  J Transl Med       Date:  2020-01-06       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.